PHARMA-TECH A/S — Credit Rating and Financial Key Figures
CVR number: 32940897
Messingvej 23, 8940 Randers SV
mail@pharma-tech.dk
tel: 86481166
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 15 286.58 | 28 973.16 | 18 037.79 | 19 733.42 | 24 106.59 |
Employee benefit expenses | -8 827.35 | -10 680.06 | -10 810.31 | -10 839.42 | -12 019.53 |
Other operating expenses | -18.15 | ||||
Total depreciation | -1 691.63 | -2 936.23 | -3 048.73 | -3 132.31 | -3 521.26 |
EBIT | 4 767.60 | 15 356.87 | 4 160.60 | 5 761.69 | 8 565.80 |
Other financial income | 1.25 | 31.65 | 0.46 | 2.79 | |
Other financial expenses | - 259.01 | - 169.35 | - 172.46 | - 197.30 | - 289.50 |
Pre-tax profit | 4 509.85 | 15 219.17 | 3 988.60 | 5 564.39 | 8 279.08 |
Income taxes | -1 003.99 | -3 350.72 | - 877.55 | -1 228.46 | -1 825.98 |
Net earnings | 3 505.85 | 11 868.45 | 3 111.04 | 4 335.93 | 6 453.10 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Buildings | 891.72 | 2 045.56 | 2 100.92 | 1 676.51 | 1 252.70 |
Machinery and equipment | 6 719.57 | 9 773.52 | 11 253.65 | 11 662.34 | 14 124.97 |
Advance payments and construction in progress | 1 329.28 | 396.16 | 690.41 | 756.80 | 4 478.80 |
Tangible assets total | 8 940.56 | 12 215.24 | 14 044.98 | 14 095.66 | 19 856.47 |
Investments total | |||||
Non-current other receivables | 711.41 | 774.51 | 775.39 | 788.89 | 843.89 |
Long term receivables total | 711.41 | 774.51 | 775.39 | 788.89 | 843.89 |
Raw materials and consumables | 1 549.09 | 1 446.52 | 2 866.25 | 2 883.36 | 3 035.71 |
Finished products/goods | 4 262.51 | 5 115.98 | 4 987.77 | 4 608.86 | 3 977.98 |
Advance payments | 262.32 | 111.23 | 123.77 | 240.44 | 694.78 |
Inventories total | 6 073.93 | 6 673.73 | 7 977.79 | 7 732.65 | 7 708.47 |
Current trade debtors | 4 865.99 | 5 496.19 | 4 881.78 | 5 758.63 | 9 781.22 |
Prepayments and accrued income | 134.47 | 91.94 | 395.05 | 72.06 | 738.24 |
Current other receivables | 57.40 | 224.67 | 350.08 | 7.47 | 0.09 |
Current deferred tax assets | 261.03 | ||||
Short term receivables total | 5 057.85 | 6 073.84 | 5 626.91 | 5 838.17 | 10 519.55 |
Cash and bank deposits | 557.36 | 4 782.12 | 234.66 | 1 015.98 | 1 639.95 |
Cash and cash equivalents | 557.36 | 4 782.12 | 234.66 | 1 015.98 | 1 639.95 |
Balance sheet total (assets) | 21 341.12 | 30 519.44 | 28 659.74 | 29 471.34 | 40 568.33 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
Shares repurchased | 8 000.00 | 2 000.00 | 2 000.00 | 8 000.00 | |
Retained earnings | 6 446.08 | 1 951.93 | 11 820.38 | 12 931.43 | 9 267.35 |
Profit of the financial year | 3 505.85 | 11 868.45 | 3 111.04 | 4 335.93 | 6 453.10 |
Shareholders equity total | 10 451.94 | 22 320.39 | 17 431.43 | 19 767.35 | 24 220.45 |
Provisions | 39.09 | 134.84 | 266.22 | 245.89 | 184.78 |
Non-current leasing loans | 4 225.84 | 1 899.33 | 1 440.64 | 3 522.22 | 6 703.08 |
Non-current other liabilities | 36.33 | 66.11 | |||
Non-current liabilities total | 4 262.17 | 1 965.45 | 1 440.64 | 3 522.22 | 6 703.08 |
Current loans from credit institutions | 3 413.19 | 459.00 | 3 460.42 | 534.80 | 11.62 |
Current trade creditors | 1 864.82 | 2 267.79 | 2 607.29 | 1 284.54 | 4 877.98 |
Current owed to participating | 2 058.78 | 2 029.69 | 6.88 | ||
Short-term deferred tax liabilities | 221.37 | 232.17 | 364.79 | 1 051.09 | |
Other non-interest bearing current liabilities | 1 088.54 | 3 371.98 | 1 162.78 | 1 722.06 | 3 512.44 |
Current liabilities total | 6 587.93 | 6 098.77 | 9 521.45 | 5 935.88 | 9 460.01 |
Balance sheet total (liabilities) | 21 341.12 | 30 519.44 | 28 659.74 | 29 471.34 | 40 568.33 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.